WILMINGTON, Del., July 31, 2012 /PRNewswire/ -- Butamax™ Advanced Biofuels, LLC, the biobutanol technology leader, commented on the lawsuit filed by Gevo today alleging patent infringement of Gevo patent number 8,232,089.
"The Gevo '089 patent adds no new point of novelty over previous Butamax discoveries. As such, Butamax is the rightful owner and innovator of this technology," said Paul Beckwith, Butamax CEO. "We look forward to putting forth detailed evidence both to the court in response to this lawsuit and with the USPTO through its reexamination process."
In a like case, the USPTO recently granted Butamax's request for reexamination of Gevo patent number 8,101,808 rejecting all 156 claims of the patent. In that case, certain claims were rejected in view of prior Butamax inventions. Given that the Butamax inventions have been accorded significant priority over the Gevo applications, we anticipate a similar result for the '089 patent.
For additional information on Butamax technology and intellectual property, please visit: http://butamaxpatents.com/
Butamax™ Advanced Biofuels, LLC was formed to develop and commercialize biobutanol as a next generation renewable biofuel for the transport market. The company benefits from the synergy of DuPont's proven industrial biotechnology experience and BP's global fuels market knowledge. Butamax's proprietary technology offers a cost-advantaged manufacturing process for isobutanol with value from field to pump. For more information, visit www.butamaxpatents.com.
Butamax™ is a trademark of Butamax™ Advanced Biofuels, LLC.
Cory Ziskind 917-275-4793
SOURCE Butamax Advanced Biofuels, LLC